Benjamin Bowen is a Managing Director in the Investment Banking group at Northland Capital Markets focused on the healthcare sector. Dr. Bowen is also the Principal of Owatonna Advisors, Inc., a consultancy that provides scientific and business advice to early stage life science companies. Before joining Northland in 2013, Dr. Bowen was Managing Director at The Benchmark Company, LLC, and at Rodman & Renshaw, LLC. Over the course of his investment banking career, he originated nearly $3 billion in financing for early stage companies and advised numerous health care companies on strategic matters. Prior to 2004, he worked in pharmaceutical research and research management at Genentech, CIBA‐Geigy, and Novartis, as well as in healthcare-focused retained advisory services at Acumen Sciences. Dr. Bowen received his B.A. in Chemistry from Hamline University and a Ph.D. in Organic Chemistry from MIT.